Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.35 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 3/20 | 0.31 |
| ▸ | POLB | P06746 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.30 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.30 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7902097 | 0.68 | SIGMAR1 (0.34) | NPSR1KMT2AOPRM1OPRD1OPRK1 | |
| SCHEMBL11262598 | 0.68 | AKR1B1 (0.33) | AKR1B1ALDH1A1KDM4EMAPTGAA | |
| SCHEMBL7908064 | 0.67 | ADRB2 (0.33) | KDM4EMEN1KMT2AOPRM1 | |
| SCHEMBL9388439 | 0.66 | ACHE (0.36) | ALDH1A1GAAMEN1KMT2A | |
| SCHEMBL9702143 | 0.65 | MAOB (0.32) | KDM4E | |
| SCHEMBL28121196 | 0.64 | MAPT (0.35) | HRH4AKR1B1ALDH1A1KDM4EMAPT | |
| SCHEMBL9701430 | 0.63 | CA1 (0.33) | MAPTGAALMNASMN1; SMN2HTT | |
| SCHEMBL13993102 | 0.63 | ALDH1A1 (0.38) | HRH4AKR1B1ALDH1A1KDM4EMAPT | |
| SCHEMBL7904440 | 0.61 | — | — | |
| SCHEMBL9035160 | 0.59 | KMT2A (0.62) | AKR1B1ALDH1A1MAPTGAANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6201119-B1 | 2,3,4,5-TETRAHYDRO-1H-1,4-BENZODIAZEPIN-9-AMINE COMPOUNDS USEFUL AS INTERMEDIATES TO ANTIVIRALS | JANSSEN PHARMACEUTICA N.V. (BE) | 2001-03-13 | — | — | US | disclosed |
| EP-0417840-B1 | Antiviral tetrahydroimidazo [1,4]-benzodiazepines | JANSSEN PHARMACEUTICA NV (BE) | 1994-12-07 | — | — | EP | disclosed |
| US-5371079-A | Administering to inhibit replication of HIV-1 in human cells | JANSSEN PHARMACEUTICA N.V. (BE) | 1994-12-06 | — | — | US | disclosed |
| US-5270464-A | Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones | JANSSEN PHARMACEUTICA N.V. (BE) | 1993-12-14 | — | — | US | disclosed |
| EP-0491751-A1 | ANTIVIRAL TETRAHYDROIMIDAZO 1,4]BENZODIAZEPINES | JANSSEN PHARMACEUTICA N.V. (BE) | 1992-07-01 | — | — | EP | disclosed |
| WO-1991004255-A1 | ANTIVIRAL TETRAHYDROIMIDAZO[1,4]BENZODIAZEPINES | JANSSEN PHARMACEUTICA N.V. (BE) | 1991-04-04 | — | — | WO | disclosed |
| EP-0417840-A1 | Antiviral tetrahydroimidazo [1,4]-benzodiazepines | JANSSEN PHARMACEUTICA N.V. (BE) | 1991-03-20 | — | — | EP | disclosed |